FDA written feedback supports:- a single-arm, open-label registrational trial in 2nd-line refractory high-grade NMIBC with CIS- a randomized vs ...
FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...
ANKTIVA® plus checkpoint inhibitor (CPI) therapy demonstrated statistically significant immune restoration across two ...
Thrombolytic therapy with alteplase is widely used for symptomatic PVT, but evidence comparing it directly with tenecteplase ...
A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
Enliven Therapeutics (ELVN) jumped on strong ELVN-001 phase 1b CML data, but a rich valuation may cap upside—get the latest ...
In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...
News-Medical.Net on MSN
Digital coaching boosts asthma control and quality of life
While online coaching improves asthma management short-term, it does not sustain physical activity changes, highlighting the ...
This whitepaper provides MEMS engineers, biomedical device developers, and multiphysics simulation specialists with a practical AI-accelerated workflow for optimizing piezoelectric micromachined ...
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
In BREAKWATER, EC plus FOLFIRI achieved a 64.4% response rate and showed a trend toward improved overall survival in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback